{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:39:30Z","timestamp":1775723970762,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National High Technology Research and Development Program of China","award":["2012AA02A501"],"award-info":[{"award-number":["2012AA02A501"]}]},{"name":"Sun Yat-Sen University Clinical Medical Research Project 5010","award":["20130008"],"award-info":[{"award-number":["20130008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin J Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40880-016-0160-9","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T13:15:18Z","timestamp":1480079718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment"],"prefix":"10.1186","volume":"35","author":[{"given":"Wenhua","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanzhu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"issue":"8","key":"160_CR1","first-page":"381","volume":"33","author":"KR Wei","year":"2014","unstructured":"Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou ZX, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin J Cancer. 2014;33(8):381\u20137.","journal-title":"Chin J Cancer."},{"issue":"8","key":"160_CR2","first-page":"350","volume":"34","author":"LF Zhang","year":"2015","unstructured":"Zhang LF, Li YH, Xie SH, Ling W, Chen SH, Liu Q, et al. Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis. Chin J Cancer. 2015;34(8):350\u20137.","journal-title":"Chin J Cancer."},{"issue":"12","key":"160_CR3","first-page":"581","volume":"33","author":"LS Young","year":"2014","unstructured":"Young LS, Dawson CW. Epstein\u2013Barr virus and nasopharyngeal carcinoma. Chin J Cancer. 2014;33(12):581\u201390.","journal-title":"Chin J Cancer."},{"issue":"8","key":"160_CR4","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1200\/JCO.2002.08.149","volume":"20","author":"AT Chan","year":"2002","unstructured":"Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol. 2002;20(8):2038\u201344.","journal-title":"J Clin Oncol"},{"key":"160_CR5","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2009","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. Philadelphia: Lippincott-Raven; 2009.","edition":"7"},{"issue":"23","key":"160_CR6","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1200\/JCO.2010.33.1595","volume":"29","author":"V Valentini","year":"2011","unstructured":"Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163\u201372.","journal-title":"J Clin Oncol"},{"issue":"5","key":"160_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5732\/cjc.013.10137","volume":"33","author":"JY Wang","year":"2014","unstructured":"Wang JY, Zhu Y, Wang CF, Zhang SL, Dai B, Ye DW. A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients. Chin J Cancer. 2014;33(5):241\u20138.","journal-title":"Chin J Cancer."},{"issue":"11","key":"160_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1200\/JCO.2006.06.1218","volume":"25","author":"PI Karakiewicz","year":"2007","unstructured":"Karakiewicz PI, Briganti A, Chun FK, Trinh QD, Perrotte P, Ficarra V, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol. 2007;25(11):1316\u201322.","journal-title":"J Clin Oncol"},{"issue":"8","key":"160_CR9","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370.","journal-title":"J Clin Oncol"},{"issue":"21","key":"160_CR10","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res."},{"issue":"10","key":"160_CR11","first-page":"1071","volume":"69","author":"FE Harrell Jr","year":"1985","unstructured":"Harrell FE Jr, Lee KL, Matchar DB, Reichert TA. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep. 1985;69(10):1071\u20137.","journal-title":"Cancer Treat Rep"},{"key":"160_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med"},{"key":"160_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"FE Harrell Jr","year":"2001","unstructured":"Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001."},{"issue":"3","key":"160_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clon.2012.10.006","volume":"25","author":"RJ Colaco","year":"2013","unstructured":"Colaco RJ, Betts G, Donne A, Swindell R, Yap BK, Sykes AJ, et al. Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol (R Coll Radiol). 2013;25(3):171\u20137.","journal-title":"Clin Oncol (R Coll Radiol)."},{"issue":"3","key":"160_CR15","first-page":"137","volume":"34","author":"YP Chen","year":"2015","unstructured":"Chen YP, Zhao BC, Chen C, Shen LJ, Gao J, Mai ZY, et al. Pretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients. Chin J Cancer. 2015;34(3):137\u201346.","journal-title":"Chin J Cancer."},{"issue":"1","key":"160_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/etm.2013.1100","volume":"6","author":"F Kong","year":"2013","unstructured":"Kong F, Cai BZ, Chen XZ, Zhang J, Wang YM. Prognostic factors for survival of patients with nasopharyngeal carcinoma following conventional fractionation radiotherapy. Exp Ther Med. 2013;6(1):57\u201360.","journal-title":"Exp Ther Med."},{"issue":"4","key":"160_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5732\/cjc.011.10283","volume":"31","author":"G Li","year":"2012","unstructured":"Li G, Gao J, Tao YL, Xu BQ, Tu ZW, Liu ZG, et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Cancer. 2012;31(4):197\u2013206.","journal-title":"Chin J Cancer."},{"issue":"2","key":"160_CR18","first-page":"119","volume":"27","author":"YL Cai","year":"2013","unstructured":"Cai YL, Li J, Lu AY, Zhong WM, Zheng YM, Gao JQ, et al. Prognostic significance of serum anti-Epstein\u2013Barr virus antibodies in nasopharyngeal carcinoma. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013;27(2):119\u201322 (in Chinese).","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi."},{"issue":"12","key":"160_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/jjco\/hyn104","volume":"38","author":"T Nakamura","year":"2008","unstructured":"Nakamura T, Kodaira T, Tachibana H, Tomita N, Tomoda T, Nakahara R, et al. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors. Jpn J Clin Oncol. 2008;38(12):803\u20139.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"160_CR20","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ijrobp.2006.02.016","volume":"65","author":"DT Chua","year":"2006","unstructured":"Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, et al. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: subgroup analysis of two Phase III trials. Int J Radiat Oncol Biol Phys. 2006;65(5):1300\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"160_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijrobp.2004.03.002","volume":"60","author":"JC Lin","year":"2004","unstructured":"Lin JC, Liang WM, Jan JS, Jiang RS, Lin AC, et al. Another way to estimate outcome of advanced nasopharyngeal carcinoma\u2014is concurrent chemoradiotherapy adequate? Int J Radiat Oncol Biol Phys. 2004;60(1):156\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"160_CR22","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.ejca.2013.03.008","volume":"49","author":"XB Wan","year":"2013","unstructured":"Wan XB, Wei L, Li H, Dong M, Lin Q, Ma XK, et al. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma. Eur J Cancer. 2013;49(10):2356\u201364.","journal-title":"Eur J Cancer"},{"issue":"1","key":"160_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semradonc.2011.09.003","volume":"22","author":"W Neve De","year":"2012","unstructured":"De Neve W, De Gersem W, Madani I. Rational use of intensity modulated radiation therapy: the importance of clinical outcome. Semin Radiat Oncol. 2012;22(1):40\u20139.","journal-title":"Semin Radiat Oncol."},{"issue":"3","key":"160_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","volume":"104","author":"G Peng","year":"2012","unstructured":"Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):286\u201393.","journal-title":"Radiother Oncol"},{"issue":"9","key":"160_CR25","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ejca.2013.03.003","volume":"49","author":"WX Xia","year":"2013","unstructured":"Xia WX, Zhang HB, Shi JL, Lu X, Wang L, Ye YF, et al. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification. Eur J Cancer. 2013;49(9):2152\u201360.","journal-title":"Eur J Cancer."},{"issue":"11","key":"160_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.clon.2013.07.004","volume":"25","author":"H Chang","year":"2013","unstructured":"Chang H, Gao J, Xu BQ, Guo SP, Lu RB, Li G, et al. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3237 patients from a single institution. Clin Oncol (R Coll Radiol). 2013;25(11):639\u201346.","journal-title":"Clin Oncol (R Coll Radiol)."},{"issue":"2","key":"160_CR27","doi-asserted-by":"publisher","first-page":"e57830","DOI":"10.1371\/journal.pone.0057830","volume":"8","author":"H Zhang","year":"2013","unstructured":"Zhang H, Xia W, Lu X, Sun R, Wang L, Zheng L, et al. A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients. PLoS ONE. 2013;8(2):e57830.","journal-title":"PLoS ONE"},{"issue":"82","key":"160_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","volume":"127","author":"DB Rubin","year":"1997","unstructured":"Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(82):757\u201363.","journal-title":"Ann Intern Med."},{"issue":"12","key":"160_CR29","first-page":"598","volume":"33","author":"KC Chan","year":"2014","unstructured":"Chan KC. Plasma Epstein\u2013Barr virus DNA as a biomarker for nasopharyngeal carcinoma. Chin J Cancer. 2014;33(12):598\u2013603.","journal-title":"Chin J Cancer."}],"container-title":["Chinese Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-016-0160-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T20:57:49Z","timestamp":1526158669000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancercommun.biomedcentral.com\/articles\/10.1186\/s40880-016-0160-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1186\/s40880-016-0160-9","relation":{},"ISSN":["1944-446X"],"issn-type":[{"value":"1944-446X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]},"article-number":"98"}}